Cybin Inc. (CYBN)
AMEX: CYBN
· Real-Time Price · USD
8.35
-0.30 (-3.47%)
At close: Jun 13, 2025, 3:59 PM
8.40
0.60%
After-hours: Jun 13, 2025, 05:37 PM EDT
-3.47% (1D)
| Bid | 8.33 |
| Market Cap | 175.57M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -103.9M |
| EPS (ttm) | -3.84 |
| PE Ratio (ttm) | -2.17 |
| Forward PE | -1.83 |
| Analyst | Buy |
| Ask | 8.57 |
| Volume | 452,559 |
| Avg. Volume (20D) | 280,960 |
| Open | 8.50 |
| Previous Close | 8.65 |
| Day's Range | 8.24 - 8.62 |
| 52-Week Range | 4.81 - 13.88 |
| Beta | 1.13 |
About CYBN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CYBN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CYBN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
3 weeks ago · businesswire.com
Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcar...
1 month ago · businesswire.com
Cybin to Participate at the 28th Annual Milken Institute Global ConferenceTORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcar...